Immunotherapy of cancer by IL-12-based cytokine combinations

Author： Weiss Jonathan M   Subleski Jeff J   Wigginton Jon M   Wiltrout Robert H  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.7, Iss.11, 2007-11, pp. : 1705-1721

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-12 as an Adjuvant for Cancer Immunotherapy

By Rodolfo M.   Colombo M.P.  

Methods, Vol. 19, Iss. 1, 1999-09 ,pp. : 114-120

Academic Press

Access to resources Recommend Favorite

Evaluating the role of IL-12 based therapies in ovarian cancer: a review of the literature

By Whitworth Jenny M   Alvarez Ronald D  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 751-762

Informa Healthcare

Access to resources Recommend Favorite

Neutrophils in antibody-based immunotherapy of cancer

By van Egmond Marjolein  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 83-94

Informa Healthcare

Access to resources Recommend Favorite

Peptide-based vaccines for cancer immunotherapy

By Brinkman Joeli A   Fausch Steven C   Weber Jeffrey S   Kast W Martin  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 2, 2004-02 ,pp. : 181-198

Informa Healthcare

Access to resources Recommend Favorite

Clinical applications of recombinant virus-based cancer immunotherapy

By Adamina Michel   Daetwiler Silvia   Rosenthal Rachel   Zajac Paul  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 9, 2005-09 ,pp. : 1211-1224

Informa Healthcare

Access to resources Recommend Favorite